Company

The Company

Improving the
quality of life
with innovations
Start »
Diagnostic Imaging

Detecting diseases early
An early and exact diagnosis can be decisive for therapy, since it greatly influences the choice of an optimum treatment and can therefore have a positive effect on the therapeutic process. Our substances make it possible to take a precise look inside the human body, helping to quickly detect diseases in specific organs. more
General Medicine

Partner for general practitioners and specialists
In its General Medicine business area, Bayer Schering Pharma develops and markets products that are prescribed by both general practitioners and specialists.
In this area we concentrate on products for high blood pressure, coronary heart diseases, diabetes and infectious diseases, as well as erectile dysfunction and testosterone deficiency in men. more
Specialty Medicine

Alleviating the symptoms of serious illnesses
Our Specialty Medicine business unit delivers novel treatment options which can significantly improve the quality of life of people living with serious, chronic and life-threatening medical conditions. Our current portfolio includes treatments for multiple sclerosis (MS), hemophilia and certain types of cancer. more
Women's Healthcare

Specialist in women's health
Building on more than 80 years of expertise, Bayer Schering Pharma is today a leading provider in women's healthcare. We focus on three key areas: contraception, menopause management and gynecological therapies. more

Facts and Figures
Main R&D fields
Locations worldwide
Career

Facts and Figures

Activities	> 100 countries worldwide
Sales in 2009	approx. €10.5 billion
Employees	> 36,000, > 5,800 of them in research & development
Research areas	Oncology, Women’s Healthcare, Cardiology & Hematology, Diagnostic Imaging
Main research & development locations	Germany: Berlin, Wuppertal / Cologne / Leverkusen United States: Berkeley/California; Montville/New Jersey Japan: Osaka China: Beijing
Production locations	Europe, United States, Latin America and Asia
Research & development expenditure in 2009	> €1.5 billion

Location	Main field
Berlin:	Diagnostic Imaging, Oncology and Women's Healthcare
Wuppertal:	Cardiology and Oncology
Berkeley:	Applied research and life cycle management in hemophilia and Multiple Sclerosis

Locations worldwide

Bayer Schering Pharma is a globally active company with sites on all five continents. On the continents you will find our manufacturing and our research sites as well as the homepages in the countries.

Please select "Manufacturing", "Research" or "Homepages worldwide".
Click on a continent.
You will find the country information on the continents.

Image: woman with stripes of Bayer Schering Pharma colours in her face

Career

Success doesn't just happen, success is created – by motivated employees, by committed trainees, by people who want to work on improving other people's long-term quality of life.

Bayer Schering Pharma offers all such potential members of staff new challenges: new steps along their very personal career paths, attractive jobs with an innovative pharmaceutical company which, thanks to its staff, is regarded as one of the greatest in its industry.
more

Science for a better life

Health through medical progress
Bayer Schering Pharma is one of the ten largest specialty pharmaceutical companies in the world. We market our products in more than 100 countries, and in 2009 generated sales of over €10.4 billion. More than 36,000 members of staff currently work for Bayer Schering Pharma worldwide – more than 5,900 in research and development alone.

We aim to improve people’s quality of life with our products. To achieve this, we concentrate on the research and development of innovative drugs and novel therapeutic approaches. At the same time, we are constantly improving established products. In this context, Bayer Schering Pharma uses experience it has gained from over a century in the business. more